New method accelerates development of protein therapeutics

November 27, 2019

Glycosylation -- the attachment of sugars to proteins -- plays a critical role in both cellular function and in the development of therapeutics, like vaccines.

But because researchers have used mammalian cells to create the biosynthetic pathways (sets of enzyme catalysts) to build and study these sugar structures, the process has historically taken a long time and has required specialized laboratory equipment.

Northwestern Engineering researchers have now developed a quick, cell-free system to build and study these pathways. Called GlycoPRIME, the system could lead to faster development of therapeutics and a new, modular way to make medicines on demand in resource-limited settings.

"This is an exciting new method that accelerates the design and engineering of potential medicines and vaccines using glycosylation," said Michael Jewett, the Charles Deering McCormick Professor of Teaching Excellence, professor of chemical and biological engineering, and director of Northwestern's Center for Synthetic Biology, who led the research. "It's opening a new book to engineer proteins not seen in nature with specific applications."

The results were published November 27 in the journal Nature Communications. Milan Mrksich, the Henry Wade Rogers Professor of Biomedical Engineering, Chemistry, and Cell and Molecular Biology at Northwestern's McCormick School of Engineering, is a co-author on the paper. He is also the interim vice president for research at Northwestern.

A new approach to discovering glycosylation pathways

Glycosylation is important in the development of protein medicines, which include everything from anti-cancer drugs like Herceptin to flu and tetanus vaccines. Sugar structures allow these proteins to remain stable while enabling them to perform tasks, like attack a cancer cell or retrain the immune system.

Developing these medicines has generally required many years and a laboratory with highly specialized equipment to grow mammalian cells. These mammalian cells naturally produce glycosylated proteins, but are slow-growing and can be difficult to engineer, limiting the number and diversity of glycosylation structures that can be built and tested.

Jewett's lab has developed cell-free systems that create enzymes needed to create certain proteins, but up until now, these processes could not create glycosylated products without the need to reengineer living cells.

Weston Kightlinger, a PhD student in the Jewett lab, developed a new approach to build, test, and assess sets of enzymes that can modularly build sugars for protein therapeutics. The process involves producing and then mixing and matching enzymes in test tubes to discover and understand which enzymes are needed to build desired sugar structures.

Kightlinger likens the process to building a flying machine. Instead of building a bird, which is complex and difficult to create, humans build airplanes, which are much simpler than birds but can be engineered to fly just the same. "We are pipetting liquids instead of rebuilding cells," he said. "Doing this, you can go from DNA to a glycoprotein in a matter of hours rather than weeks."

In just a few months, Kightlinger used the system to construct 37 pathways, creating 23 unique sugar structures, 18 of which have never been synthesized on proteins.

"We can now mix and match to build biosynthetic pathways an order of magnitude faster than what has been conventionally done," Jewett said. "The dream is to create new-to-nature glycoproteins that could be made on-demand to develop new types of protein medicines."

A new method for developing therapeutics and vaccines

The researchers used this process to develop a protein vaccine candidate modified with a sugar structure that could trigger the immune system, as well as a therapeutic antibody fragment with a sugar that can stabilize proteins as they circulate in the body. Future works will use other pathways developed in this paper to create glycosylated protein vaccines and therapeutics that can target certain areas within the body. The system could also be used to provide modular, on-demand biomanufacturing platforms that provide medicines or vaccines in resource-limited settings.

"Because this system is so robust and simple, it can teach us more about how these sugar structures actually work," Kightlinger said. "That will allow us to optimize them to better understand which of these structures to pursue."

Northwestern University

Related Engineering Articles from Brightsurf:

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Next frontier in bacterial engineering
A new technique overcomes a serious hurdle in the field of bacterial design and engineering.

COVID-19 and the role of tissue engineering
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.

Engineering the meniscus
Damage to the meniscus is common, but there remains an unmet need for improved restorative therapies that can overcome poor healing in the avascular regions.

Artificially engineering the intestine
Short bowel syndrome is a debilitating condition with few treatment options, and these treatments have limited efficacy.

Reverse engineering the fireworks of life
An interdisciplinary team of Princeton researchers has successfully reverse engineered the components and sequence of events that lead to microtubule branching.

New method for engineering metabolic pathways
Two approaches provide a faster way to create enzymes and analyze their reactions, leading to the design of more complex molecules.

Engineering for high-speed devices
A research team from the University of Delaware has developed cutting-edge technology for photonics devices that could enable faster communications between phones and computers.

Breakthrough in blood vessel engineering
Growing functional blood vessel networks is no easy task. Previously, other groups have made networks that span millimeters in size.

Next-gen batteries possible with new engineering approach
Dramatically longer-lasting, faster-charging and safer lithium metal batteries may be possible, according to Penn State research, recently published in Nature Energy.

Read More: Engineering News and Engineering Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to